A study on peripheral motor nerve excitability in patients with ALS

Completed

• Conditions: ALS; Amyotrofische Laterale Sclerose

• Registration Number: NL-OMON25730
• Lead Sponsor: Centre for Human Drug Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 18

Inclusion Criteria

1.Ability to understand the purpose and risks of the study and provide signed and dated informed consent.

2.Aged 18 to 80 years old, inclusive, at the time of informed consent.

Exclusion Criteria

1.History of diabetes or neuropathy.

2.History of neuromuscular disorders (other than ALS) including but not limited to ALS mimic syndromes, myopathy, myasthenia gravis, and other motor neuron diseases.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the test-retest reliability of nerve excitability threshold tracking in patients with ALS.